|Articles|March 18, 2020
Three Key Critical Considerations Before Embarking on Decentralized Trials
Author(s)Oracle
- Clinical trials can be designed across a continuum of formats. - Adding decentralized elements to trials can help acquire high-quality data. - Sponsors must understand the impact across the trial landscape for success.
Newsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Related Content
Trending on PharmExec
1
Pharmaceutical Executive Daily: Shah Capital's Plan to Vote Against Novavax Board Nominees
2
Lipid Lowering with PCSK9 Inhibition: Long-Term Efficacy, Long-Standing Barriers
3
Q&A: Supply Chain Fallout From Iran War, Tariff Uncertainty
4
Roche and C4 Therapeutics Expands Partnership with $1 Billion Collaboration Agreement
5